FemGuard + Balance

Support for female hormonal balanceFemGuard + Balance features the following ingredients:Vitex Extract (Vitex agnus castus): This is the most widely used herb worldwide for balancing female hormones. This amphoteric herb lowers or raises hormone levels according to individual needs. Since most women with hormonal imbalances lack progesterone, increased progesterone action from this herb facilitates regular menstrual cycles and optimal functioning of the hypothalamic-pituitary-ovarian axis. Flavonoids isolated from vitex have been shown to have antineoplastic activity and hypoprolactinemic effects.Black cohosh (Actaea racemosa): Another botanical compound commonly used for women's health, black cohosh is traditionally used to alleviate menopausal symptoms due to its mild phytoestrogenic action and its modulation of luteinizing hormone (LH). Luteinizing hormone levels are significantly reduced by black cohosh extracts, while follicle-stimulating hormone (FSH) levels are not. Black cohosh has been shown in various studies to reduce hot flashes, night sweats, vaginal dryness and thinning hair, sleep disturbances, and emotional symptoms. Black cohosh extracts have been shown to maximize the effects of tamoxifen, although stimulatory effects on estrogen receptor-positive breast cancer cells have not been demonstrated. Extensive studies in Germany have shown that black cohosh reduces menopausal and premenopausal symptoms. The herb's antispasmodic properties can also relieve menstrual cramps.Resveratrol (Polygonum cuspidatum): Although this herb is best known for its powerful cardioprotective, antioxidant, and anticancer properties, it is also a phytoestrogen. Resveratrol provides overall antioxidant protection and a safe hormone-balancing effect, especially in menopausal and perimenopausal women.Turmeric (Curcuma longa), rosemary (Rosmarinus officinalis), grape seed (Vitis vinifera), and green tea (Camellia sinensis): This herbal combination provides a broad antioxidant effect. Many of these powerful compounds have been shown to have potential anticancer effects against women's cancers. Designs for Health uses only the highest quality standardized botanicals, including an unrivaled green tea extract with 50% EGCG.DIM (diindolylmethane) and chrysin: These two ingredients were added due to their ability to safely optimize estrogen metabolism and counteract unwanted proliferative effects. Inadequate conversion to estrogen by aromatase has been linked to certain types of breast cancer and other women's cancers. Dietary indoles, found in Brassica plants such as cabbage, broccoli, and Brussels sprouts, have been shown to provide protection against hormone-dependent cancers. Studies have shown that of all the indole metabolites, diindolylmethane (DIM) offers the greatest protection against cancer. DIM has been reported to provide benefits in women with perimenopausal symptoms, including PMS, painful or difficult periods, endometriosis, or cervical dysplasia. Women undergoing hormone replacement therapy may also benefit from DIM supplementation, which improves estrogen metabolism and reduces breast pain.Calcium and Magnesium: Supplementation with these minerals has been shown to reduce symptoms of premenstrual syndrome (PMS) and may lead to more efficient enzyme activity, fewer cramps, and healthier bone density. As with all Designs for Health products, the minerals are available in their true Albion™ chelated form for increased bioavailability.Vitamins B6, B12, and Folate (as NatureFolate™ Blend): These nutrients are included to support healthy cell differentiation, including cervical cells, to reduce the incidence of cervical dysplasia. Cervical cancer is a major health concern, with an estimated 1 in 149 Canadian women developing cancer in their lifetime. Regular gynecological checkups and Pap smears, combined with taking FemGuard + Balance, are a proactive approach to cancer prevention. Additionally, these B vitamins lower homocysteine ​​levels, a marker of heart disease, which is a leading cause of death in women, according to the Heart and Stroke Foundation.